Glaxo invests half a billion pounds in Indian consumer healthcare division

Pharmaceuticals group GlaxoSmithKline (GSK) has upped its stake in its Indian consumer healthcare subsidiary by investing over half a billion pounds in the unit.

Pharmaceuticals group GlaxoSmithKline (GSK) has upped its stake in its Indian consumer healthcare subsidiary by investing over half a billion pounds in the unit.

GSK, which first announced an open offer back in November, has now raised its stake in the Indian publicly-listed division from 43.2% to 72.5% in an effort to raise its exposure to a "key emerging market", according to the company's Chief Strategy Officer David Redfern.

The offer period (January 17th-30th) saw shareholders in GSK Consumer Healthcare Ltd validly tender 12,319,749 shares representing 29.3% of the total shares outstanding.

The offer of INR3,900 per share values the deal at INR48bn, around £568m.

Redfern said: "We are very pleased with the outcome of this transaction, which will further increase our exposure to a key emerging market.

"It is a significant vote of confidence in the long-term growth prospects of our Consumer Healthcare business in India."

Most Popular

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism
Economy

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism

Russell Napier talks to Merryn about financial repression – or "stealing money from old people slowly" – plus how Asian capitalism is taking over in t…
16 Jul 2021
Three companies that are reaping the rewards of investment
Share tips

Three companies that are reaping the rewards of investment

Professional investor Edward Wielechowski of the Odyssean Investment Trust highlights three stocks that have have invested well – and are able to deal…
19 Jul 2021
The future belongs to emerging markets – three EM stocks to buy now
Share tips

The future belongs to emerging markets – three EM stocks to buy now

Professional investor Carlos von Hardenberg of Mobius Capital Partners picks three of his favourite emerging-market stocks.
5 Jul 2021